Authors:
Elstein, D
Abrahamov, A
Hadas-Halpern, I
Zimran, A
Citation: D. Elstein et al., Clinical monitoring after cessation of enzyme replacement therapy in M. Gaucher - Reply, BR J HAEM, 113(4), 2001, pp. 1086-1087
Citation: A. Zimran et al., Children with type I Gaucher disease: Growing into adulthood with and without enzyme therapy, ISR MED ASS, 2(2), 2000, pp. 80-81
Authors:
Iancovici-Kidon, M
Sthoeger, D
Abrahamov, A
Volach, B
Beutler, E
Gelbart, T
Barak, Y
Citation: M. Iancovici-kidon et al., A new exon 9 glucose-6-phosphate dehydrogenase mutation (G6PD "Rehovot") in a Jewish Ethiopian family with variable phenotypes, BL CELL M D, 26(6), 2000, pp. 567-571
Authors:
Veinot, JP
Elstein, D
Hanania, D
Abrahamov, A
Srivatsa, S
Zimran, A
Citation: Jp. Veinot et al., Gaucher's disease with valve calcification: Possible role of Gaucher cells, bone matrix proteins and integrins, CAN J CARD, 15(2), 1999, pp. 211-216
Authors:
Gielchinsky, Y
Elstein, D
Hadas-Halpern, I
Lahad, A
Abrahamov, A
Zimran, A
Citation: Y. Gielchinsky et al., Is there a correlation between degree of splenomegaly, symptoms and hypersplenism? A study of 218 patients with Gaucher disease, BR J HAEM, 106(3), 1999, pp. 812-816
Authors:
Elstein, D
Abrahamov, A
Hadas-Halpern, I
Zimran, A
Citation: D. Elstein et al., Recommendations for diagnosis, evaluation, and monitoring of patients withGaucher disease, ARCH IN MED, 159(11), 1999, pp. 1254-1255